BLESS 2 – Concluded
16
Apr
Dr. Holcomb is pleased to announce that the clinical study - Botulinum Toxin Treatment of Glabellar Lines: Efficacy and Safety Study – is now open for patient enrollment. This Research study has been concluded. Please check back soon for more opportunities...
View More







